サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1539366

動物用分子診断市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年

Veterinary Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 250 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
動物用分子診断市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年
出版日: 2024年08月21日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchはこのほど、世界の動物用分子診断市場に関する広範な調査レポートを出版し、促進力、新たな動向、機会、課題など、主要な市場力学の徹底的な分析を提供しました。本レポートは市場情勢を包括的に理解し、利害関係者が十分な情報に基づいた意思決定を行えるよう支援します。

主要な洞察

  • 動物用分子診断市場規模（2024年）：2億1,470万米ドル
  • 市場予測金額（2033年）：4億3,770万米ドル
  • 世界市場成長率（CAGR 2024年～2033年）：8.2%

動物用分子診断市場 - 調査範囲：

動物用分子診断市場は、動物の疾病の正確な検出と分析に使用される一連の高度な診断技術を包括しています。これらの技術には、ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）、および様々な獣医学的疾患の診断に高い感度と特異性を提供するその他の分子法が含まれます。分子診断法は、ペットや家畜の病原体、遺伝的疾患、その他の健康問題を特定し、疾病管理と治療成績の改善につなげるために極めて重要です。この市場は、分子生物学の進歩、人獣共通感染症の流行増加、迅速で正確な診断ソリューションに対する需要の高まりによって促進されています。

市場成長の促進要因：

世界の動物用分子診断市場は、動物における感染症の罹患率の上昇、ペット飼育の増加、動物の健康に関する意識の高まりなど、いくつかの重要な要因によって推進されています。分子診断は正確でタイムリーな結果を提供し、効果的な疾病管理と予防に不可欠です。また、動物医療インフラの拡充や、携帯可能で使いやすい診断機器の開発など、診断技術の進歩も市場の成長に寄与しています。さらに、分子診断学と遠隔医療やデジタルヘルスソリューションの統合により、そのアクセシビリティと普及が進んでいます。

市場抑制要因：

有望な成長にもかかわらず、動物用分子診断市場は、高度な診断技術に伴う高コストや専門知識の必要性といった課題に直面しています。特に小規模の診療所では、獣医診療に分子診断を導入するために必要な初期投資が多額になる可能性があります。さらに、分子診断検査の標準化と規制に関する懸念もあり、これはその導入と信頼性に影響を及ぼす可能性があります。これらの課題に対処するには、技術の継続的な進歩、費用対効果の高いソリューション、明確な規制の枠組みが必要であり、これによって動物医療における分子診断の広範な受け入れと有効性が確保されます。

市場機会：

動物用分子診断市場は、技術革新と進化する獣医学的ニーズによって大きな成長機会がもたらされます。新規診断アッセイとプラットフォームの市場開拓は、個別化された獣医療への関心の高まりとともに、市場拡大の新たな道を開いています。疾病の早期発見と予防に対する需要の高まりは、ペットの人間化の動向と相まって、高度な分子診断の採用を促進すると予想されます。戦略的パートナーシップ、研究開発への投資、統合診断ソリューションの採用は、こうした機会を活用し、市場成長を促進しようとする企業にとって極めて重要です。

本レポートで扱う主要な質問

  • 動物用分子診断市場の世界の成長を促進する主要な要因は何か？
  • どのアプリケーションと地域が動物用分子診断の採用をリードしているか？
  • 技術進歩は、どのように獣医分子診断市場の競合情勢を再構築しているか？
  • 動物用分子診断市場の主要企業はどこで、競争力を維持するためにどのような戦略を採用しているのか？
  • 世界の動物用分子診断市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲 / 分類
  • 市場の定義 / 範囲 / 制限
  • 包含事項・除外事項

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • 市場の革新 / 開発動向

第4章 主要な成功要因

  • 主要なプロモーション戦略：メーカー別
  • 主要な規制
  • PESTEL分析
  • ポーターの分析
  • 製品発売活動
  • 製品の採用 / 使用状況分析
  • 製品のUSP / 特徴
  • 生産分析：地域別
  • 払い戻しシナリオ
  • 取引分析
  • バリューチェーン分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 製品別
    • 疾患別
    • 種別
    • エンドユーザー別
    • 国別
  • 2024年の市場シナリオ

第7章 世界市場の需要（金額または規模、百万米ドル）分析

  • 過去の市場金額（百万米ドル）分析、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測：市場分類別、2024年～2033年
    • 前年比成長動向分析
    • 絶対額の機会分析

第8章 世界市場分析：製品別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）の分析：製品別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）分析と予測：製品別、2024年～2033年
    • PCRキット
    • INAATキット
    • マイクロアレイキット
    • DNAシーケンシングキット
  • 市場の魅力分析：製品別

第9章 世界市場分析：疾患別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）の分析：疾患別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）分析と予測：疾患別、2024年～2033年
    • アナプラズマ属
    • エーリキア属
    • ニューキャッスル病
    • インフルエンザ
    • 豚繁殖呼吸器症候群（PRRS）
    • その他
  • 市場の魅力分析：疾患別

第10章 世界市場分析：種別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）の分析：種別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測：種別、2024年～2033年
    • 家畜
    • ペット
  • 市場の魅力分析：種別

第11章 世界市場分析：エンドユーザー別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）の分析：エンドユーザー別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測：エンドユーザー別、2024年～2033年
    • 動物病院
    • 臨床検査室
    • 獣医学研究機関
  • 市場の魅力分析：エンドユーザー別

第12章 世界市場分析：地域別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）の分析：地域別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）分析予測：地域別、2024年～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第13章 北米市場分析

第14章 ラテンアメリカ市場分析

第15章 欧州市場分析

第16章 東アジア市場分析

第17章 南アジア市場分析

第18章 オセアニア市場分析

第19章 中東・アフリカ（MEA）市場分析

第20章 市場構造分析

  • 市場分析：企業階層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第21章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細情報
    • bioMerieux SA
    • IDEXX Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Qiagen NV
    • Neogen Corporation
    • ID. Vet
    • INDICAL BIOSCIENCE GmbH
    • Veterinary Molecular Diagnostics, Inc.

第22章 使用される前提条件と頭字語

第23章 調査手法

目次
Product Code: PMRREP12874

Persistence Market Research has recently published an extensive report on the global Veterinary Molecular Diagnostics market, providing a thorough analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report delivers a comprehensive understanding of the market landscape, helping stakeholders make informed decisions.

Key Insights:

  • Veterinary Molecular Diagnostics Market Size (2024E): USD 214.7 Mn
  • Projected Market Value (2033F): USD 437.7 Mn
  • Global Market Growth Rate (CAGR 2024 to 2033): 8.2%

Veterinary Molecular Diagnostics Market - Report Scope:

The Veterinary Molecular Diagnostics market encompasses a range of advanced diagnostic technologies used for the precise detection and analysis of diseases in animals. These technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS), and other molecular methods that offer high sensitivity and specificity for diagnosing various veterinary conditions. Molecular diagnostics are crucial for identifying pathogens, genetic disorders, and other health issues in pets and livestock, leading to improved disease management and treatment outcomes. The market is driven by advancements in molecular biology, the increasing prevalence of zoonotic diseases, and the growing demand for rapid and accurate diagnostic solutions.

Market Growth Drivers:

The global Veterinary Molecular Diagnostics market is propelled by several key factors, including the rising incidence of infectious diseases in animals, increased pet ownership, and growing awareness about animal health. Molecular diagnostics offer precise and timely results, which are essential for effective disease management and prevention. The expansion of veterinary healthcare infrastructure and advancements in diagnostic technologies, such as the development of portable and user-friendly diagnostic devices, are also contributing to the market's growth. Additionally, the integration of molecular diagnostics with telemedicine and digital health solutions is enhancing their accessibility and adoption.

Market Restraints:

Despite its promising growth, the Veterinary Molecular Diagnostics market faces challenges such as high costs associated with advanced diagnostic technologies and the need for specialized expertise. The initial investment required for implementing molecular diagnostics in veterinary practices can be significant, especially for smaller clinics. Additionally, there are concerns related to the standardization and regulation of molecular diagnostic tests, which can impact their adoption and reliability. Addressing these challenges requires ongoing advancements in technology, cost-effective solutions, and clear regulatory frameworks to ensure the broad acceptance and effectiveness of molecular diagnostics in veterinary care.

Market Opportunities:

The Veterinary Molecular Diagnostics market presents significant growth opportunities driven by technological innovations and evolving veterinary needs. The development of novel diagnostic assays and platforms, along with the increasing focus on personalized veterinary care, is opening new avenues for market expansion. The rising demand for early disease detection and prevention, coupled with the growing trend of pet humanization, is expected to drive the adoption of advanced molecular diagnostics. Strategic partnerships, investments in R&D, and the introduction of integrated diagnostic solutions will be crucial for companies looking to capitalize on these opportunities and drive market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Veterinary Molecular Diagnostics market globally?
  • Which applications and regions are leading the adoption of Veterinary Molecular Diagnostics?
  • How are technological advancements reshaping the competitive landscape of the Veterinary Molecular Diagnostics market?
  • Who are the key players in the Veterinary Molecular Diagnostics market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Veterinary Molecular Diagnostics market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Veterinary Molecular Diagnostics market, such as IDEXX Laboratories, Neogen Corporation, and Zoetis, are focusing on innovation, technological advancements, and strategic collaborations to maintain a competitive edge. These companies are investing heavily in R&D to develop cutting-edge diagnostic solutions that improve animal health and streamline veterinary practices. Partnerships with research institutions, technology providers, and healthcare organizations are essential for expanding market reach and enhancing diagnostic capabilities. Emphasizing accuracy, cost-effectiveness, and comprehensive diagnostic solutions are key strategies for sustaining leadership in the rapidly evolving Veterinary Molecular Diagnostics market.

Key Companies Profiled:

  • bioMerieux SA
  • IDEXX Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Qiagen N.V.
  • Neogen Corporation
  • ID. Vet
  • INDICAL BIOSCIENCE GmbH
  • Veterinary Molecular Diagnostics, Inc.

Key Segments Covered in Veterinary molecular diagnostics Industry Research

Product

  • PCR Kits
  • INAAT Kits
  • Microarray Kits
  • DNA Sequencing Kits

Disease

  • Anaplasma spp.
  • Ehrlichia spp.
  • New Castle Disease
  • Influenza
  • Porcine Reproductive & Respiratory Syndrome (PRRS)

Species

  • Livestock Animals
  • Companion Animals

End User

  • Veterinary Hospitals
  • Clinical Laboratories
  • Veterinary Research Institutes

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Market Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key Promotional Strategies, by Manufacturers
  • 4.2. Key Regulations
  • 4.3. PESTEL Analysis
  • 4.4. Porter's Analysis
  • 4.5. Product Launch Activities
  • 4.6. Product Adoption/Usage Analysis
  • 4.7. Product USPs/ Features
  • 4.8. Production Analysis by Region
  • 4.9. Reimbursement Scenario
  • 4.10. Trade Analysis
  • 4.11. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Veterinary Diagnostics Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Strategic Collaborations Among Key Players
    • 5.2.2. Rise in Awareness About Diseases in Animals Worldwide
    • 5.2.3. High Adoption of Molecular Diagnostic Kits for Veterinary Diseases
    • 5.2.4. Higher Prevalence of Chronic & Infectious Diseases in Animals
    • 5.2.5. Advancements in Molecular Technology
    • 5.2.6. Growing Acceptance of Advanced Molecular Diagnostic Techniques
    • 5.2.7. Ease in FDA Clearance for Veterinary Products
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Disease
    • 6.1.3. By Species
    • 6.1.4. By End User
    • 6.1.5. By Country
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis by Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product, 2024-2033
    • 8.3.1. PCR Kits
      • 8.3.1.1. RT-PCR Kits
      • 8.3.1.2. RAPD-PCR Kits
    • 8.3.2. INAAT Kits
    • 8.3.3. Microarray Kits
    • 8.3.4. DNA Sequencing Kits
  • 8.4. Market Attractiveness Analysis by Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Disease

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis by Disease, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Disease, 2024-2033
    • 9.3.1. Anaplasma spp.
    • 9.3.2. Ehrlichia spp.
    • 9.3.3. New Castle Disease
    • 9.3.4. Influenza
    • 9.3.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
    • 9.3.6. Others
  • 9.4. Market Attractiveness Analysis by Disease

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Species

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis by Species, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Species, 2024-2033
    • 10.3.1. Livestock Animals
      • 10.3.1.1. Porcine
      • 10.3.1.2. Poultry
      • 10.3.1.3. Bovine/Cattle
      • 10.3.1.4. Aquatic
      • 10.3.1.5. Ovine
    • 10.3.2. Companion Animals
      • 10.3.2.1. Canine
      • 10.3.2.2. Feline
      • 10.3.2.3. Avian
  • 10.4. Market Attractiveness Analysis by Species

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2033
    • 11.3.1. Veterinary Hospitals
    • 11.3.2. Clinical Laboratories
    • 11.3.3. Veterinary Research Institutes
  • 11.4. Market Attractiveness Analysis by End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis Forecast by Region, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East & Africa
  • 12.4. Market Attractiveness Analysis by Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Product
    • 13.3.3. By Disease
    • 13.3.4. By Species
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Disease
    • 13.4.4. By Species
    • 13.4.5. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Market
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By Disease
        • 13.8.1.2.3. By Species
        • 13.8.1.2.4. By End User
    • 13.8.2. Canada Market
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By Disease
        • 13.8.2.2.3. By Species
        • 13.8.2.2.4. By End User

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Product
    • 14.3.3. By Disease
    • 14.3.4. By Species
    • 14.3.5. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Disease
    • 14.4.4. By Species
    • 14.4.5. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Mexico Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Disease
        • 14.8.1.2.3. By Species
        • 14.8.1.2.4. By End User
    • 14.8.2. Brazil Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Disease
        • 14.8.2.2.3. By Species
        • 14.8.2.2.4. By End User
    • 14.8.3. Argentina Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Disease
        • 14.8.3.2.3. By Species
        • 14.8.3.2.4. By End User

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. Italy
      • 15.3.1.3. France
      • 15.3.1.4. U.K.
      • 15.3.1.5. Spain
      • 15.3.1.6. BENELUX
      • 15.3.1.7. Russia
      • 15.3.1.8. Rest of Europe
    • 15.3.2. By Product
    • 15.3.3. By Disease
    • 15.3.4. By Species
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Disease
    • 15.4.4. By Species
    • 15.4.5. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Germany Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Disease
        • 15.8.1.2.3. By Species
        • 15.8.1.2.4. By End User
    • 15.8.2. Italy Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Disease
        • 15.8.2.2.3. By Species
        • 15.8.2.2.4. By End User
    • 15.8.3. France Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Disease
        • 15.8.3.2.3. By Species
        • 15.8.3.2.4. By End User
    • 15.8.4. U.K. Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By Disease
        • 15.8.4.2.3. By Species
        • 15.8.4.2.4. By End User
    • 15.8.5. Spain Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Product
        • 15.8.5.2.2. By Disease
        • 15.8.5.2.3. By Species
        • 15.8.5.2.4. By End User
    • 15.8.6. BENELUX Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Product
        • 15.8.6.2.2. By Disease
        • 15.8.6.2.3. By Species
        • 15.8.6.2.4. By End User
    • 15.8.7. Russia Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Product
        • 15.8.7.2.2. By Disease
        • 15.8.7.2.3. By Species
        • 15.8.7.2.4. By End User

16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Product
    • 16.3.3. By Disease
    • 16.3.4. By Species
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Disease
    • 16.4.4. By Species
    • 16.4.5. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. China Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Disease
        • 16.8.1.2.3. By Species
        • 16.8.1.2.4. By End User
    • 16.8.2. Japan Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Disease
        • 16.8.2.2.3. By Species
        • 16.8.2.2.4. By End User
    • 16.8.3. South Korea Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Disease
        • 16.8.3.2.3. By Species
        • 16.8.3.2.4. By End User

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Indonesia
      • 17.3.1.3. Malaysia
      • 17.3.1.4. Thailand
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By Disease
    • 17.3.4. By Species
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Disease
    • 17.4.4. By Species
    • 17.4.5. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. India Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Disease
        • 17.8.1.2.3. By Species
        • 17.8.1.2.4. By End User
    • 17.8.2. Indonesia Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Disease
        • 17.8.2.2.3. By Species
        • 17.8.2.2.4. By End User
    • 17.8.3. Malaysia Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Disease
        • 17.8.3.2.3. By Species
        • 17.8.3.2.4. By End User
    • 17.8.4. Thailand Market Analysis
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Disease
        • 17.8.4.2.3. By Species
        • 17.8.4.2.4. By End User

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Product
    • 18.3.3. By Disease
    • 18.3.4. By Species
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Disease
    • 18.4.4. By Species
    • 18.4.5. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Disease
        • 18.8.1.2.3. By Species
        • 18.8.1.2.4. By End User
    • 18.8.2. New Zealand Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Disease
        • 18.8.2.2.3. By Species
        • 18.8.2.2.4. By End User

19. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkiye
      • 19.3.1.3. North Africa
      • 19.3.1.4. South Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Product
    • 19.3.3. By Disease
    • 19.3.4. By Species
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Disease
    • 19.4.4. By Species
    • 19.4.5. By End User
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Disease
        • 19.8.1.2.3. By Species
        • 19.8.1.2.4. By End User
    • 19.8.2. Turkiye Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Disease
        • 19.8.2.2.3. By Species
        • 19.8.2.2.4. By End User
    • 19.8.3. South Africa Market Analysis
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.3.2.1. By Product
        • 19.8.3.2.2. By Disease
        • 19.8.3.2.3. By Species
        • 19.8.3.2.4. By End User
    • 19.8.4. North Africa Market Analysis
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.4.2.1. By Product
        • 19.8.4.2.2. By Disease
        • 19.8.4.2.3. By Species
        • 19.8.4.2.4. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. bioMerieux SA
      • 21.3.1.1. Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Sales Footprint
      • 21.3.1.4. Key Financials
      • 21.3.1.5. SWOT Analysis
      • 21.3.1.6. Key Developments
      • 21.3.1.7. Strategy Overview
        • 21.3.1.7.1. Marketing Strategy
        • 21.3.1.7.2. Product Strategy
        • 21.3.1.7.3. Channel Strategy
    • 21.3.2. IDEXX Laboratories, Inc.
      • 21.3.2.1. Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Sales Footprint
      • 21.3.2.4. Key Financials
      • 21.3.2.5. SWOT Analysis
      • 21.3.2.6. Key Developments
      • 21.3.2.7. Strategy Overview
        • 21.3.2.7.1. Marketing Strategy
        • 21.3.2.7.2. Product Strategy
        • 21.3.2.7.3. Channel Strategy
    • 21.3.3. Thermo Fisher Scientific Inc.
      • 21.3.3.1. Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Sales Footprint
      • 21.3.3.4. Key Financials
      • 21.3.3.5. SWOT Analysis
      • 21.3.3.6. Key Developments
      • 21.3.3.7. Strategy Overview
        • 21.3.3.7.1. Marketing Strategy
        • 21.3.3.7.2. Product Strategy
        • 21.3.3.7.3. Channel Strategy
    • 21.3.4. Qiagen N.V.
      • 21.3.4.1. Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Sales Footprint
      • 21.3.4.4. Key Financials
      • 21.3.4.5. SWOT Analysis
      • 21.3.4.6. Key Developments
      • 21.3.4.7. Strategy Overview
        • 21.3.4.7.1. Marketing Strategy
        • 21.3.4.7.2. Product Strategy
        • 21.3.4.7.3. Channel Strategy
    • 21.3.5. Neogen Corporation
      • 21.3.5.1. Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Sales Footprint
      • 21.3.5.4. Key Financials
      • 21.3.5.5. SWOT Analysis
      • 21.3.5.6. Key Developments
      • 21.3.5.7. Strategy Overview
        • 21.3.5.7.1. Marketing Strategy
        • 21.3.5.7.2. Product Strategy
        • 21.3.5.7.3. Channel Strategy
    • 21.3.6. ID. Vet
      • 21.3.6.1. Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Sales Footprint
      • 21.3.6.4. Key Financials
      • 21.3.6.5. SWOT Analysis
      • 21.3.6.6. Key Developments
      • 21.3.6.7. Strategy Overview
        • 21.3.6.7.1. Marketing Strategy
        • 21.3.6.7.2. Product Strategy
        • 21.3.6.7.3. Channel Strategy
    • 21.3.7. INDICAL BIOSCIENCE GmbH
      • 21.3.7.1. Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Sales Footprint
      • 21.3.7.4. Key Financials
      • 21.3.7.5. SWOT Analysis
      • 21.3.7.6. Key Developments
      • 21.3.7.7. Strategy Overview
        • 21.3.7.7.1. Marketing Strategy
        • 21.3.7.7.2. Product Strategy
        • 21.3.7.7.3. Channel Strategy
    • 21.3.8. Veterinary Molecular Diagnostics, Inc.
      • 21.3.8.1. Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Sales Footprint
      • 21.3.8.4. Key Financials
      • 21.3.8.5. SWOT Analysis
      • 21.3.8.6. Key Developments
      • 21.3.8.7. Strategy Overview
        • 21.3.8.7.1. Marketing Strategy
        • 21.3.8.7.2. Product Strategy
        • 21.3.8.7.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology